Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Both laser and microneedling are effective for treating resistant alopecia areata.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Using tiny fat particles to deliver arginine to hair follicles could be a new way to treat hair loss.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Alopecia areata can sometimes appear as a straight line of hair loss instead of round patches.

Patients with Alopecia Areata have higher levels of certain inflammatory markers.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

AIMP1 can boost hair growth by increasing stem cell activity.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

The study suggests that changes in immune system receptors and their interaction with a cell component may be important in the development of a type of hair loss condition.

IL-15 helps protect hair follicles from immune attacks and encourages hair growth.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Cinainu is effective and safe for treating children's alopecia areata.

The multi-injection plate is a less painful and more efficient method for treating patchy hair loss.

FCO2 laser is a better treatment for alopecia areata than intralesional steroids.

N‐AOHPA is a promising alternative to traditional surfactants for better hair conditioning.

Injectable biostimulators can improve skin by boosting collagen and fat cell activity, but more research is needed to confirm their safety and effectiveness.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Baricitinib is effective as a treatment for severe hair loss.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

A new treatment using special microneedles and a nitric oxide-releasing drug could improve hair growth and be more convenient for people with hair loss.

HB24 helps convert IBA to IAA, promoting root hair growth.

The new hair loss treatment combining nitric oxide and minoxidil in a special carrier is effective for hair regrowth.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.